2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma
Petrylak, D.P, Tagawa, S.T, Kohli, M, Eisen, A, Canil, C, Sridhar, S.S, Spira, A, Yu, E.Y, Burke, J.M, Shaffer, D, Pan, C.X, Kim, J.J, Aragon-Ching, J.B, Tang, S, Zhang, H, Cavanaugh, C.T, Kauh, J.S, Walgren, R.A, Chi, K.N
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
300 LY2801653: an Orally Bioavailable Small Molecule Kinase Inhibitor of MET with Inhibitory Activity Against the Oncoproteins ROS1 and MKNK1/2
Thobe, M.N, Konicek, B.W, Peek, V.L, Baker, J.A. Roseberry, Um, S.L, Graff, J.R, Walgren, R.A, Pei, H, Burkholder, T.P, Yan, S.B
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
CO114 Real-World Experience Among Patients with Mantle Cell Lymphoma after Covalent Bruton Tyrosine Kinase Inhibitor Use in the United States: A Retrospective Electronic Health Record-Derived Study
Hess, L., Khanal, M., Sugihara, T., Winfree, K., Konig, H., Abada, P.B., Goebel, B., Walgren, R.A.
Published in Value in health (01.06.2023)
Published in Value in health (01.06.2023)
Get full text
Journal Article
Cisplatin and gemcitabine plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: A double-blind, randomized phase 2 trial
Valle, J.W., Bousmans, N., Zhang, W., Walgren, R.A., Vogel, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
RANGE: A randomized, double-blind, placebo-controlled phase 3 study of docetaxel (DOC) with or without ramucirumab (RAM) in platinum-refractory advanced or metastatic urothelial carcinoma
Petrylak, D.P., Chi, K.N., Drakaki, A., Sternberg, C.N., de Wit, R., Nishiyama, H., Yu, E.Y., Castellano, D., Hussain, S., Percent, I.J., Fléchon, A., Bamias, A., van der Heijden, M.S., Matsubara, N., Alekseev, B., Walgren, R.A., Hamid, O., Zimmermann, A.H., Bell-Mcguinn, K.M., Powles, T.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
RANGE, a phase III, randomized, placebo-controlled, double-blind trial of ramucirumab (RAM) and docetaxel (DOC) in platinum-refractory urothelial carcinoma (UC): Overall survival results
Petrylak, D.P., Sternberg, C.N., Drakaki, A., de Wit, R., Nishiyama, H., Necchi, A., Castellano, D., Bamias, A., Chi, K.N., van der Heijden, M.S., Matsubara, N., Hussain, S., Flechon, A., Alekseev, B.Y., Yu, E.Y., Walgren, R.A., Russo, F., Zimmermann, A.H., Bell-Mcguinn, K.M., Powles, T.B.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Comprehensive Genomic Copy Number and Sequence Analysis of 28 Chromosome 5q31.2 Candidate Genes in De Novo MDS
Graubert, Timothy A., Payton, M.A., Monahan, R.S., Shao, J., Frater, J.L., Walgren, R.A., Kasai, Y., Walter, Matthew J.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells
Walgren, R.A, Walle, U.K, Walle, T. (Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425 (USA))
Published in Biochemical Pharmacology (United Kingdom) (1998)
Get more information
Published in Biochemical Pharmacology (United Kingdom) (1998)
Publication